2018. Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis. Revista Alergia México. 65, 2 (Jul. 2018), 192–196. DOI:https://doi.org/10.29262/ram.v65i2.292.